The invention relates to a solubilisation product consisting of resveratrol,polysorbate 80 and polysorbate 20 as well asat least one medium-chain triglyceride and tocopherol for use as apharmaceutical product. The solubilisation product can be used aspharmaceutical product in the treatment of Alzheimer's disease, Friedreich'sataxia, lysosomal diseases, in particular Tay-Sachs disease,cancer, diabetes, atherosclerosis, heart diseases, arthritis and/or autoimmunediseases.
